KONINKLIJKE PHILIPS NVR- NY (PHG) Fundamental Analysis & Valuation

NYSE:PHG • US5004723038

Current stock price

27.79 USD
-0.47 (-1.66%)
At close:
27.79 USD
0 (0%)
After Hours:

This PHG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. PHG Profitability Analysis

1.1 Basic Checks

  • In the past year PHG was profitable.
  • PHG had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: PHG reported negative net income in multiple years.
  • Of the past 5 years PHG 4 years had a positive operating cash flow.
PHG Yearly Net Income VS EBIT VS OCF VS FCFPHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

1.2 Ratios

  • With a decent Return On Assets value of 3.32%, PHG is doing good in the industry, outperforming 78.26% of the companies in the same industry.
  • PHG has a better Return On Equity (8.17%) than 79.35% of its industry peers.
  • The Return On Invested Capital of PHG (5.79%) is better than 77.17% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PHG is significantly below the industry average of 9.18%.
  • The last Return On Invested Capital (5.79%) for PHG is above the 3 year average (3.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROIC 5.79%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.67%
ROIC(5y)N/A
PHG Yearly ROA, ROE, ROICPHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • PHG has a better Profit Margin (5.02%) than 76.63% of its industry peers.
  • PHG's Profit Margin has declined in the last couple of years.
  • With a decent Operating Margin value of 7.98%, PHG is doing good in the industry, outperforming 73.91% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PHG has declined.
  • PHG has a worse Gross Margin (45.18%) than 61.96% of its industry peers.
  • In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
Industry RankSector Rank
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
PHG Yearly Profit, Operating, Gross MarginsPHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

3

2. PHG Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHG is destroying value.
  • Compared to 1 year ago, PHG has more shares outstanding
  • The number of shares outstanding for PHG has been increased compared to 5 years ago.
  • Compared to 1 year ago, PHG has a worse debt to assets ratio.
PHG Yearly Shares OutstandingPHG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHG Yearly Total Debt VS Total AssetsPHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • PHG has an Altman-Z score of 2.01. This is not the best score and indicates that PHG is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.01, PHG is doing good in the industry, outperforming 60.87% of the companies in the same industry.
  • The Debt to FCF ratio of PHG is 16.37, which is on the high side as it means it would take PHG, 16.37 years of fcf income to pay off all of its debts.
  • PHG has a better Debt to FCF ratio (16.37) than 70.65% of its industry peers.
  • A Debt/Equity ratio of 0.63 indicates that PHG is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.63, PHG is doing worse than 65.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Altman-Z 2.01
ROIC/WACC0.87
WACC6.63%
PHG Yearly LT Debt VS Equity VS FCFPHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • PHG has a Current Ratio of 1.32. This is a normal value and indicates that PHG is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.32, PHG is doing worse than 80.43% of the companies in the same industry.
  • A Quick Ratio of 0.94 indicates that PHG may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.94, PHG is doing worse than 79.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.94
PHG Yearly Current Assets VS Current LiabilitesPHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

4

3. PHG Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.11% over the past year.
  • Measured over the past years, PHG shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.62% on average per year.
  • PHG shows a decrease in Revenue. In the last year, the revenue decreased by -1.03%.
  • The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%

3.2 Future

  • PHG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.24% yearly.
  • Based on estimates for the next years, PHG will show a small growth in Revenue. The Revenue will grow by 3.78% on average per year.
EPS Next Y4.04%
EPS Next 2Y8.35%
EPS Next 3Y10.36%
EPS Next 5Y10.24%
Revenue Next Year1.29%
Revenue Next 2Y2.83%
Revenue Next 3Y3.44%
Revenue Next 5Y3.78%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHG Yearly Revenue VS EstimatesPHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHG Yearly EPS VS EstimatesPHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

5

4. PHG Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.35, the valuation of PHG can be described as correct.
  • Based on the Price/Earnings ratio, PHG is valued cheaper than 82.61% of the companies in the same industry.
  • PHG is valuated rather cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 15.74, which indicates a correct valuation of PHG.
  • Based on the Price/Forward Earnings ratio, PHG is valued cheaply inside the industry as 83.70% of the companies are valued more expensively.
  • PHG's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 16.35
Fwd PE 15.74
PHG Price Earnings VS Forward Price EarningsPHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PHG is valued cheaply inside the industry as 88.04% of the companies are valued more expensively.
  • 72.28% of the companies in the same industry are more expensive than PHG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 46.91
EV/EBITDA 11.32
PHG Per share dataPHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.05
PEG (5Y)N/A
EPS Next 2Y8.35%
EPS Next 3Y10.36%

7

5. PHG Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.18%, PHG is a good candidate for dividend investing.
  • PHG's Dividend Yield is rather good when compared to the industry average which is at 0.21. PHG pays more dividend than 98.91% of the companies in the same industry.
  • PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

  • On average, the dividend of PHG grows each year by 216.55%, which is quite nice.
  • PHG has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)216.55%
Div Incr Years0
Div Non Decr Years0
PHG Yearly Dividends per sharePHG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2025 2026 0.5 1 1.5

5.3 Sustainability

  • PHG pays out 36.65% of its income as dividend. This is a sustainable payout ratio.
  • PHG's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP36.65%
EPS Next 2Y8.35%
EPS Next 3Y10.36%
PHG Yearly Income VS Free CF VS DividendPHG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B 4B
PHG Dividend Payout.PHG Dividend Payout, showing the Payout Ratio.PHG Dividend Payout.PayoutRetained Earnings

PHG Fundamentals: All Metrics, Ratios and Statistics

KONINKLIJKE PHILIPS NVR- NY

NYSE:PHG (3/13/2026, 8:04:00 PM)

After market: 27.79 0 (0%)

27.79

-0.47 (-1.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners47.46%
Inst Owner Change-0.45%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap26.76B
Revenue(TTM)17.84B
Net Income(TTM)895.00M
Analysts75.33
Price Target34.78 (25.15%)
Short Float %0.35%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0.4
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)7.53%
PT rev (3m)7.22%
EPS NQ rev (1m)-20.3%
EPS NQ rev (3m)-14.31%
EPS NY rev (1m)0.51%
EPS NY rev (3m)-0.9%
Revenue NQ rev (1m)2.87%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-2.05%
Valuation
Industry RankSector Rank
PE 16.35
Fwd PE 15.74
P/S 1.3
P/FCF 46.91
P/OCF 19.94
P/B 2.11
P/tB N/A
EV/EBITDA 11.32
EPS(TTM)1.7
EY6.12%
EPS(NY)1.77
Fwd EY6.35%
FCF(TTM)0.59
FCFY2.13%
OCF(TTM)1.39
OCFY5.01%
SpS21.39
BVpS13.14
TBVpS-1.06
PEG (NY)4.05
PEG (5Y)N/A
Graham Number22.42
Profitability
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROCE 7.33%
ROIC 5.79%
ROICexc 6.76%
ROICexgc 23.43%
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
FCFM 2.77%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.67%
ROIC(5y)N/A
ROICexc(3y)4.2%
ROICexc(5y)N/A
ROICexgc(3y)14.46%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.19%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.56%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Debt/EBITDA 2.72
Cap/Depr 59.38%
Cap/Sales 3.75%
Interest Coverage 5.63
Cash Conversion 45.59%
Profit Quality 55.2%
Current Ratio 1.32
Quick Ratio 0.94
Altman-Z 2.01
F-Score7
WACC6.63%
ROIC/WACC0.87
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y4.04%
EPS Next 2Y8.35%
EPS Next 3Y10.36%
EPS Next 5Y10.24%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.29%
Revenue Next 2Y2.83%
Revenue Next 3Y3.44%
Revenue Next 5Y3.78%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-4.71%
EBIT Next Year68.67%
EBIT Next 3Y26.47%
EBIT Next 5Y17.86%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%

KONINKLIJKE PHILIPS NVR- NY / PHG Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PHG.


Can you provide the valuation status for KONINKLIJKE PHILIPS NVR- NY?

ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.


How profitable is KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 5 / 10.


How financially healthy is KONINKLIJKE PHILIPS NVR- NY?

The financial health rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 3 / 10.


Is the dividend of KONINKLIJKE PHILIPS NVR- NY sustainable?

The dividend rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 7 / 10 and the dividend payout ratio is 36.65%.